0001062993-23-017146.txt : 20230828 0001062993-23-017146.hdr.sgml : 20230828 20230828132948 ACCESSION NUMBER: 0001062993-23-017146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230825 FILED AS OF DATE: 20230828 DATE AS OF CHANGE: 20230828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHWARTZ NORMAN D CENTRAL INDEX KEY: 0000940805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 231213753 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-RAD LABORATORIES, INC. CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 FORMER COMPANY: FORMER CONFORMED NAME: BIO RAD LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-08-25 0000012208 BIO-RAD LABORATORIES, INC. BIO BIOB 0000940805 SCHWARTZ NORMAN D C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 1 1 1 0 Chairman, President, and CEO 0 Bio-Rad A Common Stock 2023-08-25 4 M 0 2081 0 A 429925 D Bio-Rad A Common Stock 2023-08-25 4 F 0 1032 381.78 D 428893 D Bio-Rad A Common Stock 2023-08-25 4 M 0 1266 0 A 430159 D Bio-Rad A Common Stock 2023-08-25 4 F 0 628 381.78 D 429531 D Bio-Rad A Common Stock 2023-08-25 4 M 0 1805 0 A 431336 D Bio-Rad A Common Stock 2023-08-25 4 F 0 895 381.78 D 430441 D Bio-Rad A Common Stock 2023-08-25 4 M 0 2320 0 A 432761 D Bio-Rad A Common Stock 2023-08-25 4 F 0 1151 381.78 D 431610 D Bio-Rad A Common Stock 2023-08-25 4 M 0 2600 0 A 434210 D Bio-Rad A Common Stock 2023-08-25 4 F 0 1290 381.78 D 432920 D Bio-Rad B Common Stock 2023-08-25 4 M 0 39000 117.50 A 370689 D Bio-Rad B Common Stock 2023-08-25 4 F 0 25389 381.78 D 345300 D Bio-Rad B Common Stock 12900 I By Spouse Bio-Rad B Common Stock 4060054 I By Blue Raven Partners, L.P. Restricted Stock Units 0 2023-08-25 4 M 0 2081 0 D Bio-Rad A Common Stock 2081 6245 D Restricted Stock Units 0 2023-08-25 4 M 0 1266 0 D Bio-Rad A Common Stock 1266 2532 D Restricted Stock Units 0 2023-08-25 4 M 0 1805 0 D Bio-Rad A Common Stock 1805 1805 D Restricted Stock Units 0 2023-08-25 4 M 0 2320 0 D Bio-Rad A Common Stock 2320 2320 D Restricted Stock Units 0 2023-08-25 4 M 0 2600 0 D Bio-Rad A Common Stock 2600 0 D Non-Qualified Stock Option (right to buy) 117.50 2023-08-25 4 M 0 39000 0 D 2023-09-11 Bio-Rad B Common Stock 39000 0 D Shares of Class A common stock acquired on the vesting of restricted stock units. The reporting person disclaims beneficial ownership of these shares. The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023. The option, representing a right to purchase a total of 39,000 shares, became exercisable in five equal annual installments beginning on September 11, 2014, which was the first anniversary of the date on which the option was granted. /s/ Norman Schwartz 2023-08-28